https://www.selleckchem.com/pr....oducts/fingolimod.ht
0%) who were tested for thyroid autoantibodies. The median time to onset of thyroid dysfunction after ramucirumab initiation was 275 (range, 63-553) days. Levothyroxine replacement was needed in 10 (71.4%) patients. Sixteen patients had thyroid function regularly monitored; the mean TSH level was significantly increased after ramucirumab chemotherapy compared with that at baseline (10.7 ± 10.0 mU/L vs. 4.1 ± 2.8 mU/L; p less then 0.01). Our findings indicate that ramucirumab can result in thyroid dysfunction. We propose that thyroi
Like
Comment
Share
